Invention Grant
- Patent Title: Crystalline 5-methoxy-dipropyl tryptamine compounds
-
Application No.: US18264538Application Date: 2022-01-25
-
Publication No.: US12134598B2Publication Date: 2024-11-05
- Inventor: Andrew R Chadeayne
- Applicant: CAAMTECH, INC.
- Applicant Address: US WA Issaquah
- Assignee: CAAMTECH, INC.
- Current Assignee: CAAMTECH, INC.
- Current Assignee Address: US WA Issaquah
- Agency: RAPHAEL BELLUM PLLC
- International Application: PCT/US2022/013622 WO 20220125
- International Announcement: WO2022/173584 WO 20220818
- Main IPC: C07D209/16
- IPC: C07D209/16
Abstract:
The disclosure relates to crystalline form 1 of [2-(5-methoxy-1H-indol-3-yl)ethyl]dipropylamine (5-MeO-DPT) and to crystalline form 1 of bis([2-(5-methoxy-1H-indol-3-yl)ethyl]dipropylazanium) (2E)-but-2-enedioate (5-MeO-DPT fumarate), and to pharmaceutical compositions containing the compounds and methods of treatment using them.
Public/Granted literature
- US20240043381A1 CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS Public/Granted day:2024-02-08
Information query
